Literature DB >> 30683321

Biosimilar medicines: impact, opportunities and strategies. Twelve years of experience in Europe.

Olga Delgado Sánchez1, Daniel Ginard Vicens2, Antonia Sampol Mayol3, Josefa Terrasa Pons4.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 30683321     DOI： 10.1016/j.medcli.2018.11.013

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN： 0025-7753            Impact factor:   1.725


× No keyword cloud information.
  2 in total

Review 1.  Regulatory aspects of biological medicines in Bosnia and Herzegovina.

Authors:  Biljana Tubić; Saša Jungić
Journal:  Bosn J Basic Med Sci       Date:  2022-07-29       Impact factor: 3.759

Review 2.  Barriers to Biosimilar Prescribing Incentives in the Context of Clinical Governance in Spain.

Authors:  Félix Lobo; Isabel Río-Álvarez
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.